Dupont Capital Management’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Dupont Capital Management’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-24,999	Closed	-$249K	–	1726
2022 Q3	$249K	Hold	24,999	–	–	0.01%	818
2022 Q2	$247K	Hold	24,999	–	–	0.01%	915
2022 Q1	$246K	Hold	24,999	–	–	0.01%	998
2021 Q4	$244K	Hold	24,999	–	–	0.01%	1058
2021 Q3	$245K	Hold	24,999	–	–	0.01%	1156
2021 Q2	$244K	Hold	24,999	–	–	0.01%	1269
2021 Q1	$249K	Buy	+24,999	New	+$255K	0.01%	1212

Dupont Capital Management's FLAC Position: Q4 2022 in Review

Dupont Capital Management sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 24,999 shares — an estimated $249K sold.

Dupont Capital Management first reported a position in FLAC in Q1 2021 and held it in 7 quarters. The position peaked at $249K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Dupont Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Dupont Capital Management sold 24,999 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $249K.
Dupont Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 7 quarters.
Dupont Capital Management's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $249K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Dupont Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.